KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Current Assets (2016 - 2026)

Medtronic (MDT) has disclosed Current Assets for 13 consecutive years, with $24.1 billion as the latest value for Q1 2026.

  • Quarterly Current Assets rose 6.92% to $24.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $24.1 billion through Jan 2026, up 6.92% year-over-year, with the annual reading at $23.8 billion for FY2025, 8.57% up from the prior year.
  • Current Assets hit $24.1 billion in Q1 2026 for Medtronic, roughly flat from $24.0 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $25.4 billion in Q4 2022 to a low of $21.7 billion in Q2 2023.
  • Historically, Current Assets has averaged $23.0 billion across 5 years, with a median of $22.5 billion in 2024.
  • Biggest five-year swings in Current Assets: grew 11.73% in 2022 and later dropped 13.06% in 2023.
  • Year by year, Current Assets stood at $25.4 billion in 2022, then decreased by 13.06% to $22.1 billion in 2023, then increased by 1.62% to $22.4 billion in 2024, then increased by 6.94% to $24.0 billion in 2025, then grew by 0.31% to $24.1 billion in 2026.
  • Business Quant data shows Current Assets for MDT at $24.1 billion in Q1 2026, $24.0 billion in Q4 2025, and $23.2 billion in Q3 2025.